Susquehanna Fundamental Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.01M Sell
19,750
-1,550
-7% -$80K 0.02% 834
2021
Q4
$1.07M Sell
21,300
-2,830
-12% -$140K 0.03% 626
2021
Q3
$1.16M Buy
24,130
+18,105
+300% +$921K 0.02% 806
2021
Q2
$317K Sell
6,025
-67,656
-92% -$3.53M 0.01% 1349
2021
Q1
$3.64M Sell
73,681
-75,190
-51% -$3.61M 0.06% 436
2020
Q4
$7.23M Buy
148,871
+52,243
+54% +$2.58M 0.13% 211
2020
Q3
$4.85M Buy
96,628
+8,784
+10% +$452K 0.14% 200
2020
Q2
$4.48M Buy
87,844
+52,536
+149% +$2.55M 0.21% 116
2020
Q1
$1.54M Buy
+35,308
New +$1.69M 0.31% 93

Other funds holding SNY

Susquehanna Fundamental Investments's SNY Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Sanofi (SNY) stake by 7.3% in Q1 2022, selling an estimated $80K and leaving 19,750 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #834.

Susquehanna Fundamental Investments first reported a position in SNY in Q1 2020 and has held it in 9 quarters since. The position peaked at $7.23M in Q4 2020. 624 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Susquehanna Fundamental Investments held 19,750 shares of Sanofi worth $1.01M as of Q1 2022.
  • Susquehanna Fundamental Investments sold 1,550 Sanofi shares in Q1 2022, an estimated $80K.
  • Sanofi made up 0.02% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #834 holding.
  • Susquehanna Fundamental Investments first reported a position in Sanofi in Q1 2020 and has held it in 9 quarters since.
  • Susquehanna Fundamental Investments's Sanofi position peaked at $7.23M in Q4 2020.
  • 624 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.